Stueland Katherine (CIK 1689575) reported 97 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-18). Recent activity: Buy WGS (18,750 shares), Sell WGS (2,140 shares), Sell WGS (5,932 shares), Sell WGS (2,429 shares), Buy WGS (6,546 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-18 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Buy | 18,750 | $0 |
| 2026-06-18 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Sell | 2,140 | $127,874 |
| 2026-06-18 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Sell | 5,932 | $360,838 |
| 2026-06-18 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Sell | 2,429 | $149,392 |
| 2026-06-11 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Buy | 6,546 | $0 |
| 2026-06-11 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Sell | 3,639 | $195,669 |
| 2026-05-01 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Buy | 3,874 | $0 |
| 2026-05-01 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Sell | 2,154 | $140,441 |
| 2026-05-01 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Sell | 18 | $1,154 |
| 2026-03-30 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Sell | 13,412 | $848,711 |
| 2026-03-30 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Sell | 13,229 | $810,805 |
| 2026-03-30 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Sell | 5,117 | $318,943 |
| 2026-03-30 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Buy | 80,000 | $0 |
| 2026-03-30 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Sell | 5,292 | $341,863 |
| 2026-03-30 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Sell | 9,883 | $644,470 |
| 2026-03-17 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Buy | 11,921 | $0 |
| 2026-03-17 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Buy | 18,750 | $0 |
| 2026-03-17 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Sell | 7,178 | $548,040 |
| 2026-03-17 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Sell | 9,229 | $711,094 |
| 2026-03-17 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Sell | 772 | $60,170 |
| 2026-03-11 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Buy | 6,546 | $0 |
| 2026-03-11 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Sell | 3,678 | $319,066 |
| 2026-03-09 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Buy | 3,404 | $299,926 |
| 2026-03-05 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Buy | 47,684 | $0 |
| 2026-03-05 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Sell | 5,861 | $454,989 |
Source: SEC Form 4 filings · as of 2026-06-18